Data di Pubblicazione:
2017
Citazione:
Marketing of unproven stem cell-based interventions: A call to action / Sipp, D., Caulfield, T., Kaye, J., Barfoot, J., Blackburn, C., Chan, S., De Luca, M., Kent, A., Mccabe, C., Munsie, M., Sleeboom-Faulkner, M., Sugarman, J., Van Zimmeren, E., Zarzeczny, A., Rasko, J.E.J.. - In: SCIENCE TRANSLATIONAL MEDICINE. - ISSN 1946-6234. - 9:397(2017), pp. eaag0426-essg0426. [10.1126/scitranslmed.aag0426]
Abstract:
Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.
Tipologia CRIS:
Articolo su rivista
Keywords:
Humans; Social Control, Formal; Stem Cell Transplantation; Stem Cells; Marketing
Elenco autori:
Sipp, D.; Caulfield, T.; Kaye, J.; Barfoot, J.; Blackburn, C.; Chan, S.; De Luca, M.; Kent, A.; Mccabe, C.; Munsie, M.; Sleeboom-Faulkner, M.; Sugarman, J.; Van Zimmeren, E.; Zarzeczny, A.; Rasko, J. E. J.
Link alla scheda completa:
Pubblicato in: